This is Part 1 of the cover story on Pharmaceuticals: Links to Part 2, Part 3 Several Taiwan biopharma companies have developed promising new drugs, and the new government taking office this month is expected to place even more emphasis on this sector. For the industry to become a major driver of economic growth, however, Taiwan…
The gene-editing technology with the unlikely name offers great potential for genetic engineering. While not yet a household word, CRISPR, the new gene-editing technology, has taken the science of genetic engineering by storm. More precise than competing technologies while involving a fraction of the time and effort, CRISPR is already having a strong impact…
Taiwan is banking hard on biopharma, and investments that were made in previous decades are now close to bearing fruit. Flush with cash and success, some of Taiwan’s most renowned biopharma firms are on the cusp of bringing to market first-in-class, breakthrough drugs targeting some of humanity’s worst scourges, such as AIDS, cancer, and hepatitis….
